A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)

Postoperative Anemia Clinical Trial

Official title:
A New Approach to a Personalized Patient Blood Management Program in Total Hip Arthroplasty

Status Completed

Clinical Trial Summary

The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany.

A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy.

The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.

Clinical Trial Description

Retrospective audit of 470 consecutive primary THA in 2013 and 2014 ;

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

Postoperative Anemia

Clinical Trial Details

NCT number	NCT02519088
Study type	Observational
Source	Krankenhaus der Barmherzigen Brüder Trier
Contact
Status	Completed
Phase	N/A
Start date	August 2015
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05384054` - Association Between Erythroferron and Perioperative Hemoglobin Levels in Patient Undergoing Heart Valve Surgery
Recruiting	`NCT05889494` - Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients	N/A
Not yet recruiting	`NCT03561480` - Effect of Postoperative Ferric Carboxymaltose	Phase 4
Not yet recruiting	`NCT03561506` - Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty	Phase 4
Completed	`NCT01913808` - Comparing Intravenous and Oral Iron in Postoperative Anemia	Phase 4